249 related articles for article (PubMed ID: 26152358)
21. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
22. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Notch signaling pathway in regulating IL-12 expression via c-Rel in activated macrophages.
Boonyatecha N; Sangphech N; Wongchana W; Kueanjinda P; Palaga T
Mol Immunol; 2012 Jul; 51(3-4):255-62. PubMed ID: 22463790
[TBL] [Abstract][Full Text] [Related]
24. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
[TBL] [Abstract][Full Text] [Related]
25. Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.
McGowan PM; Simedrea C; Ribot EJ; Foster PJ; Palmieri D; Steeg PS; Allan AL; Chambers AF
Mol Cancer Res; 2011 Jul; 9(7):834-44. PubMed ID: 21665937
[TBL] [Abstract][Full Text] [Related]
26. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
Debeb BG; Cohen EN; Boley K; Freiter EM; Li L; Robertson FM; Reuben JM; Cristofanilli M; Buchholz TA; Woodward WA
Breast Cancer Res Treat; 2012 Jul; 134(2):495-510. PubMed ID: 22547109
[TBL] [Abstract][Full Text] [Related]
27. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
28. The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.
Han J; Ma I; Hendzel MJ; Allalunis-Turner J
Breast Cancer Res; 2009; 11(4):R57. PubMed ID: 19660128
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.
Yang H; Zhou H; Feng P; Zhou X; Wen H; Xie X; Shen H; Zhu X
J Exp Clin Cancer Res; 2010 Jul; 29(1):92. PubMed ID: 20618976
[TBL] [Abstract][Full Text] [Related]
30. Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells.
Qiu M; Peng Q; Jiang I; Carroll C; Han G; Rymer I; Lippincott J; Zachwieja J; Gajiwala K; Kraynov E; Thibault S; Stone D; Gao Y; Sofia S; Gallo J; Li G; Yang J; Li K; Wei P
Cancer Lett; 2013 Jan; 328(2):261-70. PubMed ID: 23041621
[TBL] [Abstract][Full Text] [Related]
31. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
Kim SH; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855
[TBL] [Abstract][Full Text] [Related]
32. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.
Singh JK; Farnie G; Bundred NJ; Simões BM; Shergill A; Landberg G; Howell SJ; Clarke RB
Clin Cancer Res; 2013 Feb; 19(3):643-56. PubMed ID: 23149820
[TBL] [Abstract][Full Text] [Related]
33. Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch.
Haughian JM; Pinto MP; Harrell JC; Bliesner BS; Joensuu KM; Dye WW; Sartorius CA; Tan AC; Heikkilä P; Perou CM; Horwitz KB
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2742-7. PubMed ID: 21969591
[TBL] [Abstract][Full Text] [Related]
34. Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.
Knight BB; Oprea-Ilies GM; Nagalingam A; Yang L; Cohen C; Saxena NK; Sharma D
Endocr Relat Cancer; 2011 Aug; 18(4):413-28. PubMed ID: 21555376
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells.
Xing F; Okuda H; Watabe M; Kobayashi A; Pai SK; Liu W; Pandey PR; Fukuda K; Hirota S; Sugai T; Wakabayshi G; Koeda K; Kashiwaba M; Suzuki K; Chiba T; Endo M; Mo YY; Watabe K
Oncogene; 2011 Sep; 30(39):4075-86. PubMed ID: 21499308
[TBL] [Abstract][Full Text] [Related]
36. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling.
Subramaniam D; Ponnurangam S; Ramamoorthy P; Standing D; Battafarano RJ; Anant S; Sharma P
PLoS One; 2012; 7(2):e30590. PubMed ID: 22363450
[TBL] [Abstract][Full Text] [Related]
37. GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.
Meng X; Matlawska-Wasowska K; Girodon F; Mazel T; Willman CL; Atlas S; Chen IM; Harvey RC; Hunger SP; Ness SA; Winter SS; Wilson BS
Leukemia; 2011 Jul; 25(7):1135-46. PubMed ID: 21494254
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
Belyea BC; Naini S; Bentley RC; Linardic CM
Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
Dai L; He J; Liu Y; Byun J; Vivekanandan A; Pennathur S; Fan X; Lubman DM
Proteomics; 2011 Dec; 11(23):4529-40. PubMed ID: 21932445
[TBL] [Abstract][Full Text] [Related]
40. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.
Lee CW; Raskett CM; Prudovsky I; Altieri DC
Cancer Res; 2008 Jul; 68(13):5273-81. PubMed ID: 18593928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
